Year: 2024

Celltrion-CI

Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024

logo-28

India Green Hydrogen Sector Opportunity, Government Incentives & Projects Insights 2024: National Green Hydrogen Mission Sets Target of Green Hydrogen Capacity: 5 MMT by 2030 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Green Hydrogen Sector Opportunity, Government Incentives & Projects Insights 2024" report has been added to ResearchAndMarkets.com's offering....

logo-27

New Zealand Telecoms Industry Report 2024-2031, Featuring Profiles of Spark New Zealand, One New Zealand, 2Degrees, Chorus and Mercury – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "New Zealand Telecoms Industry Report: 2024-2031" report has been added to ResearchAndMarkets.com's offering. The New Zealand Telecommunications Industry...